See QCDx POSTER at the 16th Annual ADC Conference in London (February 24-25)
TECHNOLOGY
The RareScope™ system addresses the unmet need for enrichment-free profiling and isolation of rare Circulating Tumor Cells (CTCs) by 3D optical tomography of all nucleated cells from a blood sample.
When a biopsy is not an option, CTC can offer real-time cancer intelligence with a frequent, minimally invasive blood test.
The novel MultiFluor™ multiplex immunofluorescent probes will enable rapid CTC profiling with 12+ biomarkers in intact & live cells at the time of detection. Different fluorescent antibody probe combinations can be utilized for personalized and real-time intelligence on treatment-specific markers also in all cytology and cytopathology applications.
Our combined RareScope™ & MultiFluor™ platform has multiple applications In cancer diagnostics, cancer research and the pharmaceutical industry in all stages of drug discovery and clinical trials.
RareScope™ for Rare Cell Profiling
The RareScope analyzes cells from the patient’s blood, without the need of a microscopy slide.
Cells are visualized morphologically intact after immuno-fluorescent or Fluorescence In Situ Hybridization (FISH) staining by utilizing 3D tomographic microscopy. Several million cells can be visualized also live, immobilized in life-sustaining hydrogel.
ENRICHMENT-FREE rare cell detection and deep characterization
INTACT CELL visualization in a life-sustaining 3-D suspension
LIVE CELL visualization over long periods of time
SINGLE CELL isolation - intact and live
3D-CULTURE of cells under continual visualization